ReviewOncoTargets and therapy2017
Current status of poly(ADP-ribose) polymerase inhibitors and future directions.
Akihiro Ohmoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
66 papers cite itlatest 60 shown
this paperpooled ittrialcites it